{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T01:37:06Z","timestamp":1788745026757,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,29]],"date-time":"2017-04-29T00:00:00Z","timestamp":1493424000000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["N01AI85346"],"award-info":[{"award-number":["N01AI85346"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI065683"],"award-info":[{"award-number":["U19AI065683"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center, National Institutes of Health","doi-asserted-by":"publisher","award":["D43TW001589"],"award-info":[{"award-number":["D43TW001589"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"United States Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-06-1-0427"],"award-info":[{"award-number":["W81XWH-06-1-0427"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"United States Agency for International Development, Washington, D.C.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Military Infectious Diseases Research Program"},{"name":"International Collaboration on Infectious Diseases Research","award":["U01AI065683-06"],"award-info":[{"award-number":["U01AI065683-06"]}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.vaccine.2016.04.019","type":"journal-article","created":{"date-parts":[[2016,4,15]],"date-time":"2016-04-15T07:52:17Z","timestamp":1460706737000},"page":"2546-2555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Strain-specific Plasmodium falciparum multifunctional CD4+ T cell cytokine expression in Malian children immunized with the FMP2.1\/AS02A vaccine candidate"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2359-2382","authenticated-orcid":false,"given":"Shawna F.","family":"Graves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bourema","family":"Kouriba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issa","family":"Diarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modibo","family":"Daou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amadou","family":"Niangaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drissa","family":"Coulibaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamoussa","family":"Keita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B.","family":"Laurens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea A.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Vekemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Ripley Ballou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Lanar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheetij","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gray Heppner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Soisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carter L.","family":"Diggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahamadou A.","family":"Thera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ogobara K.","family":"Doumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher V.","family":"Plowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo B.","family":"Sztein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten E.","family":"Lyke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.04.019_bib0215","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1172\/JCI62182","article-title":"Targets of antibodies against Plasmodium falciparum-infected erythrocytes in malaria immunity","volume":"122","author":"Chan","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0220","doi-asserted-by":"crossref","first-page":"e24852","DOI":"10.1371\/journal.pone.0024852","article-title":"Age-related differences in naturally acquired T cell memory to Plasmodium falciparum merozoite surface protein 1","volume":"6","author":"Chelimo","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0225","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/cid\/cit174","article-title":"An intensive longitudinal cohort study of Malian children and adults reveals no evidence of acquired immunity to Plasmodium falciparum infection","volume":"57","author":"Tran","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0230","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/1471-2148-11-299","article-title":"Timing the origin of human malarias: the lemur puzzle","volume":"11","author":"Pacheco","year":"2011","journal-title":"BMC Evol Biol"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0235","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-3024.2009.01138.x","article-title":"Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming \u2018vaccine resistant malaria\u2019","volume":"31","author":"Takala","year":"2009","journal-title":"Parasit Immunol"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0240","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/infdis\/jis709","article-title":"Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications","volume":"207","author":"Ouattara","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0245","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.vaccine.2012.12.039","article-title":"Within-population genetic diversity of Plasmodium falciparum vaccine candidate antigens reveals geographic distance from a Central sub-Saharan African origin","volume":"31","author":"Tanabe","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0250","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nature01107","article-title":"A proteomic view of the Plasmodium falciparum life cycle","volume":"419","author":"Florens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0255","doi-asserted-by":"crossref","first-page":"23890","DOI":"10.1074\/jbc.M302160200","article-title":"A single malaria merozoite serine protease mediates shedding of multiple surface proteins by juxtamembrane cleavage","volume":"278","author":"Howell","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0260","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1074\/jbc.M311331200","article-title":"A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites","volume":"279","author":"Silvie","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0265","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0166-6851(84)90112-9","article-title":"The Fab fragments of monoclonal IgG to a merozoite surface antigen inhibit Plasmodium knowlesi invasion of erythrocytes","volume":"13","author":"Thomas","year":"1984","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0270","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1128\/IAI.69.5.3286-3294.2001","article-title":"Specificity of the protective antibody response to apical membrane antigen 1","volume":"69","author":"Hodder","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0275","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/IAI.72.1.154-158.2004","article-title":"Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells","volume":"72","author":"Mitchell","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0280","doi-asserted-by":"crossref","first-page":"12488","DOI":"10.1073\/pnas.0701464104","article-title":"Structural basis of antigenic escape of a malaria vaccine candidate","volume":"104","author":"Dutta","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0285","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.chom.2010.12.003","article-title":"Super-resolution dissection of coordinated events during malaria parasite invasion of the human erythrocyte","volume":"9","author":"Riglar","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0290","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-3024.1988.tb00241.x","article-title":"Vaccination trials in rhesus monkeys with a minor, invariant, Plasmodium knowlesi 66kD merozoite antigen","volume":"10","author":"Deans","year":"1988","journal-title":"Parasit Immunol"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0295","doi-asserted-by":"crossref","first-page":"711","DOI":"10.4269\/ajtmh.1994.51.711","article-title":"Protective immunity induced in squirrel monkeys with recombinant apical membrane antigen-1 of Plasmodium fragile","volume":"51","author":"Collins","year":"1994","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0300","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0264-410X(97)88331-4","article-title":"Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi","volume":"16","author":"Anders","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0305","doi-asserted-by":"crossref","first-page":"6961","DOI":"10.1128\/IAI.70.12.6961-6967.2002","article-title":"Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria","volume":"70","author":"Stowers","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0310","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4049\/jimmunol.165.1.389","article-title":"CD4+ T cells acting independently of antibody contribute to protective immunity to Plasmodium chabaudi infection after apical membrane antigen 1 immunization","volume":"165","author":"Xu","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0315","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1008115","article-title":"A field trial to assess a blood-stage malaria vaccine","volume":"365","author":"Thera","year":"2011","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0320","doi-asserted-by":"crossref","first-page":"2ra5","DOI":"10.1126\/scitranslmed.3000257","article-title":"Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development","volume":"1","author":"Takala","year":"2009","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0325","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1016\/j.vaccine.2007.03.012","article-title":"Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naive adults at the Walter Reed Army Institute of Research","volume":"25","author":"Polhemus","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0330","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.vaccine.2009.01.097","article-title":"Cell-mediated immunity elicited by the blood stage malaria vaccine apical membrane antigen 1 in Malian adults: results of a Phase I randomized trial","volume":"27","author":"Lyke","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0335","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/1475-2875-13-374","article-title":"Stable malaria incidence despite scaling up control strategies in a malaria vaccine-testing site in Mali","volume":"13","author":"Coulibaly","year":"2014","journal-title":"Malar J"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0340","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/j.vaccine.2004.01.054","article-title":"Incidence of severe Plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in Bandiagara, Mali","volume":"22","author":"Lyke","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0345","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.1128\/IAI.01822-05","article-title":"Effects of concomitant Schistosoma haematobium infection on the serum cytokine levels elicited by acute Plasmodium falciparum malaria infection in Malian children","volume":"74","author":"Lyke","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0350","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.1128\/IAI.73.9.5799-5808.2005","article-title":"HLA-A2 supertype-restricted cell-mediated immunity by peripheral blood mononuclear cells derived from Malian children with severe or uncomplicated Plasmodium falciparum malaria and healthy controls","volume":"73","author":"Lyke","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0355","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1128\/IAI.70.6.3101-3110.2002","article-title":"Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli","volume":"70","author":"Dutta","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0360","doi-asserted-by":"crossref","first-page":"e31647","DOI":"10.1371\/journal.pone.0031647","article-title":"Reduced T regulatory cell response during acute Plasmodium falciparum infection in Malian children co-infected with Schistosoma haematobium","volume":"7","author":"Lyke","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0365","doi-asserted-by":"crossref","first-page":"e37868","DOI":"10.1371\/journal.pone.0037868","article-title":"Antigen-specific B memory cell responses to Plasmodium falciparum malaria antigens and Schistosoma haematobium antigens in co-infected Malian children","volume":"7","author":"Lyke","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0370","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0375","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/infdis\/jit134","article-title":"Humoral and cellular immunity to Plasmodium falciparum merozoite surface protein 1 and protection from infection with blood-stage parasites","volume":"208","author":"Moormann","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0380","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1473-3099(02)00344-4","article-title":"The immune response to Plasmodium falciparum malaria","volume":"2","author":"Malaguarnera","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0385","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/iai.63.2.596-600.1995","article-title":"Humoral and cell-mediated immunity to the Plasmodium falciparum ring-infected erythrocyte surface antigen in an adult population exposed to highly endemic malaria","volume":"63","author":"Beck","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0390","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0395","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1126\/science.1211548","article-title":"Live attenuated malaria vaccine designed to protect through hepatic CD8(+) T cell immunity","volume":"334","author":"Epstein","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0400","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1586\/14760584.6.5.723","article-title":"GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives","volume":"6","author":"Garcon","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0405","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1038\/nm1210","article-title":"Targeting the innate immune response with improved vaccine adjuvants","volume":"11","author":"Pashine","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0410","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1586\/14760584.2.2.231","article-title":"Development of RTS,S\/AS02: a purified subunit-based malaria vaccine candidate formulated with a novel adjuvant","volume":"2","author":"Garcon","year":"2003","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0415","doi-asserted-by":"crossref","first-page":"e20775","DOI":"10.1371\/journal.pone.0020775","article-title":"Protective immunity induced with the RTS,S\/AS vaccine is associated with IL-2 and TNF-alpha producing effector and central memory CD4 T cells","volume":"6","author":"Lumsden","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.04.019_bib0420","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1128\/CVI.00133-10","article-title":"Evaluation of the safety and immunogenicity of two antigen concentrations of the Mtb72F\/AS02(A) candidate tuberculosis vaccine in purified protein derivative-negative adults","volume":"17","author":"Leroux-Roels","year":"2010","journal-title":"Clin Vaccine Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16301487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16301487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T05:57:22Z","timestamp":1712383042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16301487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":42,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0264410X16301487"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.04.019","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strain-specific Plasmodium falciparum multifunctional CD4+ T cell cytokine expression in Malian children immunized with the FMP2.1\/AS02A vaccine candidate","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}